期刊文献+

Hepatocellular Carcinoma with Gastric Metastasis Mimicking a 4 cm Gastrointestinal Stromal Tumor After a 3-year Disease-free Interval

原文传递
导出
摘要 Hepatocellular carcinoma(HCC)is an aggressive tumor that usually occurs in patients with chronic liver disease and cirrhosis.Surgical resection is an optimal treatment for HCC,but the 5-year recurrence rates are significantly high.The majority of recurrent HCCs occur through intrahepatic metastasis with local tumor progression,and less than 20%of recurrences are extrahepatic metastases.HCC with gastric metastasis is extremely rare,and it is easily misdiagnosed as primary gastric cancer with liver metastasis.An 80-yearold male chronic hepatitis B virus carrier had received lamivudine and entecavir for years and was regularly followed up in the clinic.He had a 3.5 cm solitary HCC with microvascular invasion and received curative surgical resection in 2009.In 2013,he developed a 1.3 cm solitary HCC again and was treated with combination therapy with radiofrequency ablation and pure ethanol injection.Afterwards,he was followed every 3–6 months and was HCC-free.Three years later,in 2016,endoscopy for intermittent epigastralgia showed a solitary 4 cm intraluminal gastric subepithelial tumor without mucosal ulcers or erosions over the gastric fundus.All imaging studies,including computed tomography,favored the diagnosis of gastrointestinal stromal tumor(GIST),but the pathology of the tumor proved to be HCC.The patient did not receive any systemic anticancer therapy but only wedge resection of the stomach and remained tumor-and HCC-free until his latest clinic visit in 2023.The current case is unique and indicates the possibility of HCC with late solitary gastric metastasis mimicking GIST.Complete gastric tumor resection ensured an extremely good outcome for the patient,which is different from the devastating prognosis of most cases of HCC with gastric metastasis.
出处 《Journal of Clinical and Translational Hepatology》 SCIE 2024年第2期218-221,共4页 临床与转化肝病杂志(英文版)
基金 supported by grants from the Chang Gung Medical Research Program(CMRPG3I0413,CMRPG3L1191,CMRPG3M0211,and CMRPG1K0111-3) the National Science Council,Taiwan(MOST 110-2629-B-182-001-,110-2314-B-182-044-,111-2629-B-182-001-,and 111-2314-B-182A-156-).
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部